Aquilo Capital Management, LLC Merus N.V. Transaction History

Aquilo Capital Management, LLC

$100 Million
Q2 2024

A detailed history of Aquilo Capital Management, LLC transactions in Merus N.V. stock. As of the latest transaction made, Aquilo Capital Management, LLC holds 148,109 shares of MRUS stock, worth $7.45 Million. This represents 8.76% of its overall portfolio holdings.

Number of Shares

148,109

Previous 255,109 41.94%

Holding current value

$7.45 Million

Previous $11.5 Million 23.71%

% of portfolio

8.76%

Previous 8.96%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$39.81 - $60.2 $4.26 Million - $6.44 Million	-107,000 Reduced 41.94%	148,109 $8.76 Million
Q1 2024 May 15, 2024	SELL	$28.03 - $51.82 $2.8 Million - $5.18 Million	-100,000 Reduced 28.16%	255,109 $11.5 Million
Q4 2023 Feb 14, 2024	SELL	$20.06 - $28.66 $1.5 Million - $2.15 Million	-75,000 Reduced 17.44%	355,109 $9.77 Million
Q3 2023 Nov 14, 2023	SELL	$20.13 - $27.29 $6.94 Million - $9.42 Million	-345,000 Reduced 44.51%	430,109 $10.1 Million
Q2 2023 Aug 14, 2023	SELL	$18.33 - $27.18 $8.25 Million - $12.2 Million	-450,000 Reduced 36.73%	775,109 $20.4 Million
Q1 2023 May 15, 2023	SELL	$14.25 - $20.5 $2.95 Million - $4.24 Million	-207,000 Reduced 14.45%	1,225,109 $22.5 Million
Q4 2022 Feb 14, 2023	SELL	$12.8 - $23.66 $960,000 - $1.77 Million	-75,000 Reduced 4.98%	1,432,109 $22.2 Million
Q3 2022 Nov 14, 2022	BUY	$18.64 - $28.93 $559,200 - $867,900	30,000 Added 2.03%	1,507,109 $30.2 Million
Q2 2022 Aug 15, 2022	BUY	$13.98 - $29.25 $3.01 Million - $6.31 Million	215,575 Added 17.09%	1,477,109 $33.4 Million
Q1 2022 May 16, 2022	BUY	$23.58 - $30.91 $8.61 Million - $11.3 Million	365,032 Added 40.72%	1,261,534 $33.4 Million
Q4 2021 Feb 14, 2022	BUY	$20.0 - $32.29 $17.9 Million - $28.9 Million	896,502 New	896,502 $28.5 Million
Q2 2020 Aug 14, 2020	SELL	$10.5 - $17.36 $8.09 Million - $13.4 Million	-770,183 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$11.34 - $19.44 $3.05 Million - $5.22 Million	-268,563 Reduced 25.85%	770,183 $9.32 Million
Q3 2019 Nov 14, 2019	SELL	$14.55 - $20.52 $5.13 Million - $7.24 Million	-352,751 Reduced 25.35%	1,038,746 $18.5 Million
Q2 2019 Aug 14, 2019	SELL	$12.93 - $16.83 $1.29 Million - $1.68 Million	-100,000 Reduced 6.7%	1,391,497 $20.4 Million
Q1 2019 May 15, 2019	BUY	$11.09 - $15.83 $118,019 - $168,462	10,642 Added 0.72%	1,491,497 $22 Million
Q4 2018 Feb 14, 2019	BUY	$11.46 - $20.81 $2.12 Million - $3.85 Million	185,142 Added 14.29%	1,480,855 $20.7 Million
Q3 2018 Nov 14, 2018	BUY	$18.47 - $26.39 $827,437 - $1.18 Million	44,799 Added 3.58%	1,295,713 $25.6 Million
Q2 2018 Aug 14, 2018	BUY	$16.77 - $22.76 $21 Million - $28.5 Million	1,250,914 New	1,250,914 $28.5 Million

Others Institutions Holding MRUS

# of Institutions

194

Shares Held

59.2M

Call Options Held

345K

Put Options Held

222K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.31B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquilo Capital Management, LLC with notifications on news.

Account

Aquilo Capital Management, LLC Merus N.V. Transaction History